Minidose heparin therapy for vasculitis of atrophie blanche

Robert L. Jetton, Gerald S. Lazarus

Research output: Contribution to journalArticlepeer-review

Abstract

Atrophie blanche vasculitis is due to thromboocclusion of dermal blood vessels. A 28-year-old white man with a very severe case of this disease had a complete remission when he was treated with minidose heparin sodium injections. As little as 5,000 U of heparin every 3 days controlled his vasculitis. Further reduction of heparin dose resulted in an exacerbation of disease which was controlled with more vigorous heparin therapy. The role of minidose heparin in cutaneous disease is discussed.

Original languageEnglish (US)
Pages (from-to)23-26
Number of pages4
JournalJournal of the American Academy of Dermatology
Volume8
Issue number1
DOIs
StatePublished - Jan 1 1983
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Minidose heparin therapy for vasculitis of atrophie blanche'. Together they form a unique fingerprint.

Cite this